enterotrack

enterotrack

Innovative esophageal monitoring for EoE patients using non-invasive fluid biopsy technology. Learn more
  • Edit
DateInvestorsAmountRound
N/A

$250k

Seed
*

N/A

-
Total Funding$250k

Recent News about enterotrack

Edit
More about enterotrackinfo icon
Edit

EnteroTrack LLC specializes in providing a non-invasive solution for monitoring eosinophilic esophagitis (EoE) through its proprietary Esophageal String and EnteroTracker technology. This innovative approach allows physicians to easily and routinely collect mucosal fluid samples from the upper gastrointestinal tract of both adult and pediatric patients without the need for endoscopy or biopsy. The collected samples are then analyzed using a lab-developed test, with results promptly delivered back to the physician. EnteroTrack operates in the healthcare and medical device market, primarily serving physicians and patients dealing with EoE. The company's business model revolves around the sale of its Esophageal String device, which is available by prescription in the USA. Revenue is generated through the sale of these devices and associated lab testing services.

Keywords: EoE, esophageal monitoring, non-invasive, fluid biopsy, EnteroTracker, mucosal sampling, pediatric, adult, healthcare, medical device.